SAMSUNG PHARM. Co., LTD. (001360.KS)
KRW 1603.0
(0.25%)
KRW 1603.0
(0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 51.95 Billion | 51.83 Billion | 54.9 Billion | 48.26 Billion | 44.56 Billion | 46.48 Billion |
| Cost of Revenue | 28.2 Billion | 27.21 Billion | 45.61 Billion | 37.81 Billion | 35.16 Billion | 37.89 Billion |
| Gross Profit | 23.74 Billion | 24.61 Billion | 9.28 Billion | 10.45 Billion | 9.39 Billion | 8.58 Billion |
| Operating Expenses | 41.78 Billion | 38.58 Billion | 27.42 Billion | 20.24 Billion | 14.62 Billion | 13.37 Billion |
| Selling, General and Administrative Expenses | 37.94 Billion | 32.68 Billion | 20.45 Billion | 10.78 Billion | 4.81 Billion | 5.54 Billion |
| Research and Development Expenses | 3.68 Billion | 327.02 Million | 650.53 Million | 663.57 Million | 90.93 Million | 377.5 Million |
| Other Expenses | -159.18 Million | 5.56 Billion | 6.31 Billion | 8.79 Billion | 9.71 Billion | 7.44 Billion |
| Cost and Expenses | 69.99 Billion | 65.79 Billion | 73.04 Billion | 58.06 Billion | 49.78 Billion | 51.26 Billion |
| Operating Income | -18.04 Billion | -13.96 Billion | -18.13 Billion | -9.79 Billion | -5.22 Billion | -3.26 Billion |
| Interest Expense | 73.36 Million | 111.09 Million | 506.87 Million | 2.08 Billion | 707.58 Million | 1.35 Billion |
| Income Tax Expense | 1.13 Billion | 11.86 Billion | 22.4 Billion | 23.88 Billion | 201.66 Million | 59.55 Million |
| Earnings before Tax | -23.67 Billion | -25.09 Billion | -40.27 Billion | -39.87 Billion | 7.08 Billion | -2.01 Billion |
| Net Income | -24.81 Billion | -36.95 Billion | -62.67 Billion | -63.76 Billion | 6.88 Billion | -2.07 Billion |
| Earnings Per Share Basic | -333.83 | -496.74 | -852.31 | -941.87 | 106.06 | -40.51 |
| Earnings Per Share Diluted | -333.83 | -496.74 | -852.31 | -941.87 | 106.06 | -40.51 |
| Weighted Average Shares Outstanding | 74.32 Million | 74.39 Million | 73.53 Million | 67.69 Million | 64.91 Million | 51.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.32 Million | 74.39 Million | 73.53 Million | 67.69 Million | 64.91 Million | 51.23 Million |
| Gross Margin | 0.46 | 0.47 | 0.17 | 0.22 | 0.21 | 0.18 |
| EBIT Margin | -0.42 | -0.20 | -0.27 | -0.24 | -0.04 | 0.01 |
| Profit Margin | -0.48 | -0.71 | -1.14 | -1.32 | 0.15 | -0.04 |
| EBITDA | -21.68 Billion | -21.97 Billion | -36.45 Billion | -25.32 Billion | 12.42 Billion | 3.1 Billion |
| Earnings Before Tax Margin | -0.35 | -0.27 | -0.33 | -0.20 | -0.12 | -0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 10.57 Billion | 12.16 Billion | 51.95 Billion | 12.02 Billion | 11.71 Billion | 14.97 Billion |
| Cost of Revenue | 5.15 Billion | 6.81 Billion | 28.2 Billion | 8.05 Billion | 6.06 Billion | 6.91 Billion |
| Gross Profit | 5.42 Billion | 5.35 Billion | 23.74 Billion | 3.96 Billion | 5.64 Billion | 8.06 Billion |
| Operating Expenses | 11.6 Billion | 7.5 Billion | 41.78 Billion | 9.15 Billion | -9.06 Billion | -11.89 Billion |
| Selling, General and Administrative Expenses | 10.06 Billion | 6.95 Billion | - | 8.24 Billion | 9.06 Billion | 11.89 Billion |
| Research and Development Expenses | 1.5 Billion | 520.02 Million | - | 885.2 Million | 573.65 Million | 242.71 Million |
| Other Expenses | -37.66 Million | -33.56 Million | -159.18 Million | -23.7 Million | -18.12 Billion | -23.78 Billion |
| Cost and Expenses | 16.75 Billion | 14.32 Billion | 69.99 Billion | 17.21 Billion | 6.06 Billion | 6.91 Billion |
| Operating Income | -6.17 Billion | -2.15 Billion | -18.04 Billion | -5.19 Billion | -3.41 Billion | -3.82 Billion |
| Interest Expense | 52.95 Million | 39.08 Million | 73.36 Million | 13.4 Million | 16.88 Million | 18.16 Million |
| Income Tax Expense | - | 450.9 Million | 1.13 Billion | 1.13 Billion | 9.06 Billion | 11.89 Billion |
| Earnings before Tax | -10.27 Billion | -4.8 Billion | -23.67 Billion | -11.02 Billion | -6.24 Billion | -3.6 Billion |
| Net Income | -10.27 Billion | -4.8 Billion | -24.81 Billion | -12.16 Billion | -6.24 Billion | -3.6 Billion |
| Earnings Per Share Basic | -109.18 | -61.35 | - | -163.48 | -83.92 | -48.40 |
| Earnings Per Share Diluted | -109.18 | -61.35 | - | -163.48 | -83.92 | -48.40 |
| Weighted Average Shares Outstanding | 94.12 Million | 78.39 Million | 74.39 Million | 74.39 Million | 74.39 Million | 74.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 94.12 Million | 78.39 Million | 74.39 Million | 74.39 Million | 74.39 Million | 74.39 Million |
| Gross Margin | 0.51 | 0.44 | 0.46 | 0.33 | 0.48 | 0.54 |
| EBIT Margin | -0.54 | -0.14 | - | -0.39 | 0.48 | 0.54 |
| Profit Margin | -0.97 | -0.40 | -0.48 | -1.01 | -0.53 | -0.24 |
| EBITDA | -5.72 Billion | -1.7 Billion | - | -4.69 Billion | 5.64 Billion | 8.06 Billion |
| Earnings Before Tax Margin | -0.58 | -0.18 | -0.35 | -0.43 | -0.29 | -0.26 |
300457
RWC
SEQI
2379
0592
VBNK